Paydirt
OCX
Ticker

Oncocyte Corp

OCX

Oncocyte Corp (OCX) has 4 disclosed filings on Paydirt over the past 24 months from 3 corporate insiders: 4 purchases and 0 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Feb 7 2025 and filed Feb 11 2025. The most active filer was Patrick W Smith with 2 filings. Data as of Nov 8 2026.

Add to watchlist
Filings, 24m
4
4 buys · 0 sells
Traders, 24m
3
3 insiders
Volume, 24miDollar value disclosed in the window
$13.2M
estimated for Congress, as filed for insiders
Median delay
4d
execution to disclosure
Last traded
Feb 7 2025
Filed Feb 11 2025
ADViAverage daily dollar volume
–
not on file

No price series on file for OCX yet.

Volume by month
$13.0M$6.5M$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · buys $192KFeb 2025 · buys $13.0M
Buys $13.2M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
PS Patrick W Smith CHIEF EXECUTIVE OFFICER 2 filings · 2 buys, 0 sales BP Broadwood Partners, L.P. Director 1 filing · 1 buy, 0 sales AJ Andrea S. James Chief Financial Officer 1 filing · 1 buy, 0 sales
Recent filings
Patrick W SmithPURCHASE 10% owner $2.2M
1,077,600 sh × $2.05
Exec Feb 7 2025
Filed Feb 11 2025 · 5:30 PM ET Andrea S. JamesPURCHASE Chief Financial Officer $200K
97,561 sh × $2.05
Exec Feb 7 2025
Filed Feb 11 2025 · 5:30 PM ET Broadwood Partners, L.P.PURCHASE 10% owner $10.6M
5,165,695 sh across 2 lots
Exec Feb 6 2025
Filed Feb 10 2025 · 5:30 PM ET Patrick W SmithPURCHASE 10% owner $192K
90,219 sh × $2.13
Exec Dec 26 2024
Filed Dec 27 2024 · 5:30 PM ET